Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
Population
Patients at high risk of sudden cardiac death, including early phase after acute myocardial infarction with…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May support WCD bridging for high-risk SCD patients; leaves open need for RCTs to confirm outcomes and guide adoption.
Structured PICO
P
Population
Patients at high risk of sudden cardiac death, including early phase after acute myocardial infarction with poor left ventricular function, post-revascularization with LVEF ≤35%, acute heart failure in non-ischaemic cardiomyopathy, syncope of assumed tachyarrhythmia origin, inherited arrhythmia syndromes, or awaiting heart transplantation/ventricular-assist device.
I
Intervention
Wearable cardioverter-defibrillator (WCD)
The wearable cardioverter-defibrillator serves as a safe and effective temporary bridging therapy for patients at high risk of sudden cardiac death while awaiting definitive risk stratification or ICD implantation.
Cite This Study
Klein et al. (2013) studied this question.